Jaguar Animal Health, Inc. (NASDAQ:JAGX) reached 150% versus a 1-year low price of $0.5. The stock was last seen 5.93% higher, reaching at $1.25 on Mar. 10, 2017. At recent session, the prices were hovering between $1.17 and $1.26. This company shares are 420% off its target price of $6.5 and the current market capitalization stands at $16.93M. The recent change has given its price a 52.59% lead over SMA 50 and -67.02% deficit over its 52-week high. The stock witnessed 66.2% gains, 78.6% gains and -4.07% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found JAGX’s volatility during a week at 14.27% and during a month it has been found around 17.56%.Jaguar Animal Health, Inc. (JAGX) Top Holders
Institutional investors currently hold around $4 million or 26.1% in JAGX stock. Look at its top three institutional owners. Invesco Ltd. owns $2.33 million in Jaguar Animal Health, Inc., which represents roughly 13.76% of the company’s market cap and approximately 58.25% of the institutional ownership. Similar statistics are true for the second largest owner, Kingdon Capital Management, L.L.C., which owns 1,297,815 shares of the stock are valued at $1.53 million. The third largest holder is Anson Funds Management Lp, which currently holds $222 thousand worth of this stock and that ownership represents nearly 1.31% of its market capitalization.Jaguar Animal Health, Inc. 13F Filings
At the end of 12/31/2016 reporting period, 5 institutional holders increased their position in Jaguar Animal Health, Inc. (NASDAQ:JAGX) by some 522,388 shares, 3 decreased positions by 21,206 and 4 held positions by 3,102,553. That puts total institutional holdings at 3,646,147 shares, according to SEC filings. The stock grabbed 1 new institutional investments totaling 188,200 shares while 3 institutional investors sold out their entire positions totaling 21,206 shares.Jaguar Animal Health, Inc. (JAGX) Analyst Guide
Not many analysts have released their opinion on Jaguar Animal Health, Inc. (NASDAQ:JAGX), with 1 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.5 average brokerage recommendation.